Leeina Hoff
Family · Walnut Creek, CANPI 1578910923
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations.
Across 112 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$352
- Johnson & Johnson$332
- Daiichi Sankyo Inc.$225
- Merck$173
- GSK$150
- E.r. Squibb & Sons, L.L.C.$136
- plus $1K from 33 others
What the payments were for
- Food & beverage$2,73397%
- Education$943%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $352 |
| Johnson & Johnson(2 entities) | 13 | $332 |
| Daiichi Sankyo Inc. | 10 | $225 |
| Merck | 7 | $173 |
| GSK | 5 | $150 |
| E.r. Squibb & Sons, L.L.C. | 9 | $136 |
| Pfizer | 4 | $110 |
| Beone Medicines USA, Inc. | 4 | $102 |
| Sanofi | 3 | $102 |
| Array Biopharma Inc | 3 | $86 |
| Seagen Inc. | 1 | $78 |
| Deciphera Pharmaceuticals Inc. | 2 | $72 |
| Genentech USA, Inc. | 2 | $66 |
| Astellas Pharma US Inc | 3 | $60 |
| Kyowa Kirin, Inc. | 2 | $59 |
| Recordati_rare_diseases_inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Bristol Myers Squibb | 2 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Spectrum Pharmaceuticals Inc. | 1 | $40 |
| Agios Pharmaceuticals, Inc. | 2 | $33 |
| Blueprint Medicines Corporation | 1 | $33 |
| Sun Pharmaceutical Industries Inc. | 2 | $32 |
| Eisai Inc. | 1 | $31 |
| Sobi, Inc | 1 | $30 |
| Stemline Therapeutics Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $29 |
| Novartis | 1 | $28 |
| Taiho Oncology, Inc. | 1 | $27 |
| Gilead | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $25 |
| Corcept Therapeutics | 1 | $25 |
| Progenics Pharmaceuticals, Inc. | 1 | $24 |
| Puma Biotechnology, Inc. | 1 | $24 |
| Incyte Corporation | 1 | $22 |
| Accord Healthcare, Inc. | 1 | $19 |
| Bayer | 1 | $19 |
| Menarini Silicon Biosystems, Inc. | 1 | $15 |
| Pharmaand GmbH | 1 | $10 |
How this compares
$2,827 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Other family in Walnut Creek
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.